tradingkey.logo
tradingkey.logo
検索

Biomerica Inc

BMRA
ウォッチリストに追加
1.750USD
-0.020-1.13%
終値 07/02, 13:00ET15分遅れの株価
5.16M時価総額
損失額直近12ヶ月PER

詳細情報 Biomerica Inc 企業名

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Biomerica Incの企業情報

企業コードBMRA
会社名Biomerica Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Irani (Zackary S)
従業員数53
証券種類Ordinary Share
決算期末Mar 17
本社所在地17571 Von Karman Avenue
都市IRVINE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号92614
電話番号19493792875
ウェブサイトhttps://biomerica.com/
企業コードBMRA
上場日Mar 17, 1980
最高経営責任者「CEO」Irani (Zackary S)

Biomerica Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--

よくある質問

Biomerica Incの上位5名の株主は誰ですか?

Biomerica Incの上位5名の株主は以下のとおりです。Mr. Zackary S. Irani

Biomerica Inc(BMRA)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Biomerica Incの株式を保有している機関は59社あり、保有株式の総市場価値は約94.38Kで、全体の3.05%を占めています。2025Q4と比較して、機関の持ち株は-250592.00増加しています。

Biomerica Incの最大の収益源は何ですか?

2026Q1において、Clinical Lab部門がBiomerica Incにとって最大の収益を生み出しており、その金額は676.00Kで、全収益の55.87%を占めています。